secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2023-04-03T23:59:59+00:00
Accession:  0001104659-23-040523
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics appoints Dr. Arroyo as CDO, promotes Perry to SVP Commercial; CMO leaves
--------------------------------------------------------------------------------

- Santiago Arroyo appointed Chief Development Officer effective March 31, 2023; formerly CMO at Momenta and Fulcrum.
- Jennifer Perry promoted to Senior Vice President, Commercial; over 20 years pharma experience in oncology.
- Dominic Smethurst, former Chief Medical Officer, has left the company; CEO thanked him for contributions.
- Arroyo to oversee pipeline expansion and late-stage development; Perry to build commercial organization.
- Company advancing oncology programs BT8009, BT5528, and BT7480 in the clinic.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923040523/0001104659-23-040523-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923040523/tm2311247d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-040523

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer